Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5301
CALL
Corvus Pharmaceuticals
CRVS
$1.24B
| $499K | ﹤0.01% |
+103,100
| New | +$305K |
|
|
AVAN
5302
CALL
DELISTED
Avanti Acquisition Corp.
AVAN
| $499K | ﹤0.01% |
763,488
+3,134
| +0.4% | +$30.5K |
|
5303
New Fortress Energy
NFE
$87.1M
| $498K | ﹤0.01% |
17,955
+3,641
| +25% | +$110K |
|
5304
Redwire
RDW
$2.82B
| $498K | ﹤0.01% |
51,719
-244,469
| -83% | -$2.55M |
|
5305
QCR Holdings
QCRH
$1.65B
| $497K | ﹤0.01% |
+9,660
| New | +$477K |
|
|
BCLI
5306
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $496K | ﹤0.01% |
10,022
-14,742
| -60% | -$776K |
|
5307
CALL
Aurora
AUR
$11.4B
| $495K | ﹤0.01% |
329,710
-67,855
| -17% | -$671K |
|
5308
Super Micro Computer
SMCI
$24.9B
| $494K | ﹤0.01% |
+135,200
| New | +$490K |
|
5309
iShares 0-5 Year TIPS Bond ETF
STIP
$16.1B
| $494K | ﹤0.01% |
+4,672
| New | +$496K |
|
|
LUCK
5310
CALL
Lucky Strike Entertainment
LUCK
$854M
| $494K | ﹤0.01% |
358,332
+241,666
| +207% | +$2.39M |
|
5311
PG&E
PCG
$39.5B
| $493K | ﹤0.01% |
51,360
-88,176
| -63% | -$832K |
|
|
FBMS
5312
DELISTED
The First Bancshares, Inc.
FBMS
| $493K | ﹤0.01% |
12,723
+1,612
| +15% | +$62.2K |
|
5313
CALL
Nucor
NUE
$57.3B
| $492K | ﹤0.01% |
5,000
-45,500
| -90% | -$4.84M |
|
5314
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$296M
| $492K | ﹤0.01% |
26,803
-6,773
| -20% | -$119K |
|
5315
Chesapeake Utilities
CPK
$3.21B
| $491K | ﹤0.01% |
4,086
+971
| +31% | +$122K |
|
5316
Maui Land & Pineapple Co
MLP
$315M
| $491K | ﹤0.01% |
47,368
-38,907
| -45% | -$416K |
|
5317
PUT
Navient
NAVI
$873M
| $491K | ﹤0.01% |
24,900
-100,000
| -80% | -$2.15M |
|
5318
PUT
Weyerhaeuser
WY
$17.1B
| $491K | ﹤0.01% |
+13,800
| New | +$483K |
|
5319
iShares MSCI USA Momentum Factor ETF
MTUM
$24.7B
| $490K | ﹤0.01% |
+2,789
| New | +$496K |
|
|
SEPAU
5320
DELISTED
SEP Acquisition Corp Unit
SEPAU
| $490K | ﹤0.01% |
+48,750
| New | +$485K |
|
5321
MiMedx Group
MDXG
$657M
| $489K | ﹤0.01% |
+80,696
| New | +$910K |
|
5322
Weyco Group
WEYS
$428M
| $488K | ﹤0.01% |
21,533
-41,351
| -66% | -$950K |
|
5323
Carlisle Companies
CSL
$14.3B
| $487K | ﹤0.01% |
2,452
-20,949
| -90% | -$4.23M |
|
|
NM
5324
DELISTED
Navios Maritime Holdings Inc.
NM
| $487K | ﹤0.01% |
102,091
+83,525
| +450% | +$419K |
|
|
NGCA
5325
CALL
DELISTED
NextGen Acquisition Corp. II Class A Ordinary Shares
NGCA
| $487K | ﹤0.01% |
290,000
+90,000
| +45% | +$891K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.